Molecular design and bioavailability

被引:5
作者
Clark, RD [1 ]
Wolohan, PRN [1 ]
机构
[1] Tripos Inc, St Louis, MO 63144 USA
关键词
D O I
10.2174/1568026033451952
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A "snapshot" of current medicinal chemistry work on bioavailability is drawn from issues of J. Med. Chem. covering the time period between September 2001 and September 2002. An exhaustive compilation of reported absolute oral bioavailability (F) values for this period is included, covering 34 structural series and 107 distinct compounds, with data for multiple species in many cases. This is supplemented with a discussion of more qualitative oral bioavailability results, and with illustrative examples addressing clearance, prodrug design, and blood/brain barrier penetration problems. Papers discussing predictions pertaining to one or another aspect of bioavailability are also discussed, and some thoughts on future directions of work on in silico prediction in this area are presented.
引用
收藏
页码:1269 / 1288
页数:20
相关论文
共 68 条
[41]   6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic β-cells [J].
Nielsen, FE ;
Bodvarsdottir, TB ;
Worsaae, A ;
MacKay, P ;
Stidsen, CE ;
Boonen, HCM ;
Pridal, L ;
Arkhammar, POG ;
Wahl, P ;
Ynddal, L ;
Junager, F ;
Dragsted, N ;
Tagmose, TM ;
Mogensen, JP ;
Koch, A ;
Treppendahl, SP ;
Hansen, JB .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (19) :4171-4187
[42]  
Oprea TI, 2001, RATIONAL APPROACHES TO DRUG DESIGN, P437
[43]   Chemography: The art of navigating in chemical space [J].
Oprea, TI ;
Gottfries, J .
JOURNAL OF COMBINATORIAL CHEMISTRY, 2001, 3 (02) :157-166
[44]   Discovery of 4-[(Z)-(4-bromophenyl)-(ethoxyimino)methyll-1′-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4′-methyl-1,4′-bipiperidine N-oxide (SCH 351125):: An orally bioavailable human CCR5 antagonist for the treatment of HIV infection [J].
Palani, A ;
Shapiro, S ;
Clader, JW ;
Greenlee, WJ ;
Cox, K ;
Strizki, J ;
Endres, M ;
Baroudy, BM .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (21) :3339-3342
[45]   Identification of orally active, potent, and selective 4-piperazinylquinazolines as antagonists of the platelet-derived growth factor receptor tyrosine kinase family [J].
Pandey, A ;
Volkots, DL ;
Seroogy, JM ;
Rose, JW ;
Yu, JC ;
Lambing, JL ;
Hutchaleelaha, A ;
Hollenbach, SJ ;
Abe, K ;
Giese, NA ;
Scarborough, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) :3772-3793
[46]   Trans-4-[4-(methoxyphenyl)cyclohexyll-1-arylpiperazines:: A new class of potent and selective 5-HT1A receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines [J].
Perrone, R ;
Berardi, F ;
Colabufo, NA ;
Leopoldo, M ;
Lacivita, E ;
Tortorella, V ;
Leonardi, A ;
Poggesi, E ;
Testa, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (25) :4431-4442
[47]   Discovery of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2′- (methylsulfonyl)-[1,1′-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa [J].
Pinto, DJP ;
Orwat, MJ ;
Wang, SG ;
Fevig, JM ;
Quan, ML ;
Amparo, E ;
Cacciola, J ;
Rossi, KA ;
Alexander, RS ;
Smallwood, AM ;
Luettgen, JM ;
Liang, L ;
Aungst, BJ ;
Wright, MR ;
Knabb, RM ;
Wong, PC ;
Wexler, RR ;
Lam, PYS .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (04) :566-578
[48]   Hydrophilic, pro-drug analogues of T138067 are efficacious in controlling tumor growth in vivo and show a decreased ability to cross the blood brain barrier [J].
Rubenstein, SM ;
Baichwal, V ;
Beckmann, H ;
Clark, DL ;
Frankmoelle, W ;
Roche, D ;
Santha, E ;
Schwender, S ;
Thoolen, M ;
Ye, QP ;
Jaen, JC .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (22) :3599-3605
[49]   N-arylsulfonylindole derivatives as serotonin 5-HT6 receptor ligands [J].
Russell, MGN ;
Baker, RJ ;
Barden, L ;
Beer, MS ;
Bristow, L ;
Broughton, HB ;
Knowles, M ;
McAllister, G ;
Patel, S ;
Castro, JL .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (23) :3881-3895
[50]   Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties [J].
Scozzafava, A ;
Menabuoni, L ;
Mincione, F ;
Supuran, CT .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (07) :1466-1476